当前位置: 首页 > 详情页

Global campaign against epilepsy: assessment of a demonstration project in rural China

文献详情

资源类型:

收录情况: ◇ SCIE

机构: [1]UCL Inst Neurol, Univ Dept Clin & Expt Epilepsy, WHO Collaborating Ctr Res & Training Neurosci, London WC1N 3BG, England; [2]Capital Med Univ, WHO Collaborating Ctr Res & Training Neurosci, Beijing Neurosurg Inst, Beijing, Peoples R China; [3]Universal Love Hosp, Mudanjiang, Heilongjiang Pr, Peoples R China; [4]Subei Peoples Hosp, Dept Neurol, Yangzhou, Jiangsu Prov, Peoples R China; [5]Fudan Univ, Inst Neurol, Shanghai 200433, Peoples R China; [6]Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China; [7]WHO, Dept Mental Hlth & Substance Abuse, CH-1211 Geneva, Switzerland; [8]SEIN, WHO Collaborating Ctr Res Training & Treatment Ep, Epilepsy Inst Netherlands Fdn, Achterweg, Heemstede, Netherlands; [9]UCL Inst Neurol, Univ Dept Clin & Expt Epilepsy, WHO Collaborating Ctr Res & Training Neurosci, Queen Sq, London WC1N 3BG, England
出处:
ISSN:

摘要:
Objective The Global Campaign Against Epilepsy demonstration project in rural China aimed: to reduce the treatment gap and morbidity of people with epilepsy by using community-level interventions; to train and educate health professionals; to dispel stigma; to identify potential for prevention and to develop models of integration of epilepsy control into the local health systems. We report the overall results of the demonstration project, focusing on the prevalence and the change in the treatment gap of epilepsy after an intervention. Methods Door-to-door epidemiological surveys were carried out before, and 6 months after the end of, an intervention project for epilepsy in rural settings in five provinces of China. The intervention consisted of a treatment programme available to patients without prior appropriate treatment and a public health educational programme about epilepsy. The sampled population in the second survey was 51 644 people. Findings In the second survey, epilepsy was confirmed in 320 people, yielding a lifetime prevalence of 6.2/1000 and a prevalence of active epilepsy of 4.5/1000. The lifetime prevalence and prevalence of active epilepsy in the first survey were 7.0/1000 and 4.6/1000, respectively. The treatment gap of active epilepsy in the second survey was 49.8%, 12.8 percentage points lower than that of the first survey (62.6%). Conclusion The results of this study suggest that the intervention measures used were possibly effective and evidently feasible in rural China, contributing to a decrease in the treatment gap of epilepsy.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2007]版:
大类 | 2 区 医学
最新[2025]版:
大类 | 2 区 医学
小类 | 1 区 公共卫生、环境卫生与职业卫生
JCR分区:
出版当年[2006]版:
Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH
最新[2024]版:
Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH

影响因子: 最新[2024版] 最新五年平均 出版当年[2006版] 出版当年五年平均 出版前一年[2005版] 出版后一年[2007版]

第一作者:
第一作者机构: [2]Capital Med Univ, WHO Collaborating Ctr Res & Training Neurosci, Beijing Neurosurg Inst, Beijing, Peoples R China;
通讯作者:
通讯机构: [1]UCL Inst Neurol, Univ Dept Clin & Expt Epilepsy, WHO Collaborating Ctr Res & Training Neurosci, London WC1N 3BG, England; [9]UCL Inst Neurol, Univ Dept Clin & Expt Epilepsy, WHO Collaborating Ctr Res & Training Neurosci, Queen Sq, London WC1N 3BG, England
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:18222 今日访问量:0 总访问量:997 更新日期:2025-10-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院